Antifungal Activity of Turkish Honey against Candida spp. and Trichosporon spp: an in vitro evaluation

References

• Anaissie EJ, Bodey GP, Rinaldi MG. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989; 8: 323–330.
   PubMed Web of Science ®Google Scholar
• Anaissie E, Bodey P. Disseminated trichosporonosis: meeting the challenge. Eur J Clin Microbiol Infect Dis 1991; 10: 711–713.
   Google Scholar
• Cawley MJ, Braxon GR, Haith LR, . Trichosporon beigelii infection: experience in a regional burn center. Burns 2000; 26: 483–486.
   PubMed Web of Science ®Google Scholar
• Espinel-Ingroff A. Comparison in vitro activities of the new triazole SCH 56592 and the echinocandins MK-0991 (L-743, 872) and LY 303366 against opportunistic filamenteus and dimorphic fungi and yeasts. J Clin Microbiol 1998; 36: 2950–2956.
   PubMed Web of Science ®Google Scholar
• Hoy J, Hsu KC, Rolston K, . Trichosporon beigelii infection: a review. Rev Infect Dis 1986; 8: 959–967.
   PubMedGoogle Scholar
• Trick WE, Fridkin SK, Edwards JR, Hejjeh RA, Gaynes RP. National Nosocomial Infections Surveillance System Hospitals: Secular trends of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 2002; 35: 627–230.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Jones RN, . SENTRY participant group: International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254–3259.
   PubMed Web of Science ®Google Scholar
• Rangel-Frausto MS, Wiblin T, Blumberg HM, . NEMIS study Group: National Epidomiology of Mycoses Survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29: 253–258.
   PubMed Web of Science ®Google Scholar
• Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995; 8: 462–478.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Messer SA, . In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents. Diagn Microbiol Infect Dis 2004; 48: 101–105.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick WR, Revankar SG, McAtee RK, . Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 1998; 36: 3007–3012.
   PubMed Web of Science ®Google Scholar
• Bodey GP. Azole antifungal agents. Clin Infect Dis 1992; 14: 161–169.
   PubMed Web of Science ®Google Scholar
• White TC, Marr KA, Bowden RA. Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382–402.
   PubMed Web of Science ®Google Scholar
• Cameron ML, Schell WA, Bruch S, . Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency cirus type 1. Antimicrob Agents Chemother 1993; 37: 2449–2453.
   PubMed Web of Science ®Google Scholar
• Rex JH, Pfaller MA, Galgiani JN, . Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro- in vivo correlation data for fluconazole, itraconazole, and Candida infections. Subcommittee on antifungal Susceptibility Testing of the national Committee for Clinical Laboratory standards. Clin Infect Dis 1997; 24: 235–247.
   PubMed Web of Science ®Google Scholar
• Molan PC. The antibacterial activity of honey: 2. Variation in the potency of the antibacterial activity. Bee World 1992; 73: 59–76.
   Web of Science ®Google Scholar
• Weston RJ, Mitchell KR, Allen KL. Antibacterial phenolic components of New Zealand manuka honey. Food Chem 1999; 64: 295–301.
   Web of Science ®Google Scholar
• Lusby PE, Coombes AL, Wilkinson JM. Bactericidal activity of different honeys against pathogenic bacteria. Arch Med Res 2005; 36: 464–467.
   PubMed Web of Science ®Google Scholar
• Finola MS, Lasagno MC, Marioli JM. Microbial and chemical characterization of honeys from central Argentina. Food Chem 2007; 100: 1649–1653.
   Web of Science ®Google Scholar
• Sissons CH, Anderson SA, Molan PC. Suppression of C. albicans in plaque microcosms by manuka honey. . IADR/AADR/CADR 82nd General Session in Honolulu, Hawai, 2004; .
   Google Scholar
• Boukraa L, Benbarek H, Moussa A. Synergistic action of starch and honey against C. albicans in correlation with diastase number. Braz J Microbiol 2008; 39: 40–43.
   PubMed Web of Science ®Google Scholar
• Al-Waili NS. Mixture of honey, beeswax and olive oil inhibits growth of Staphylococcus aureus and C. albicans. Arch Med Res 2005; 36: 10–13.
   PubMed Web of Science ®Google Scholar
• Irish J, Carter DA, Shokohi T, Blair SE. Honey has an antifungal effect against Candida species. Med Mycol 2006; 44: 289–291.
   PubMed Web of Science ®Google Scholar
• Louveaux J, Maurizio A, Vorwohl G. Methods of melissopalynology. Bee World 1978; 59: 139–157.
   Web of Science ®Google Scholar
• Pendleton M. Descriptions of melissoplaynological methods involving centrifugation should include data for calculating Relative Centrifugal Force (RCF) or should express data in units of RCF or gravites (g). Grana 2006; 45: 71–72.
   Web of Science ®Google Scholar
• Waren NG, Hazen NC. Candida, Cryptococcus and other yeast of medical importance. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1995; 723–737.
   Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard NCCLS document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
   Google Scholar
• MINITAB 2000. MINITAB Statistical Software, Release 13.20, Minitab Inc. State College, PA, USA.
   Google Scholar
• Al-Waili N. Therapeutic and prophylactic effects of crude honey on chronic seborrheic dermatitis and dandruff. Eur J Med Res 2001; 6: 306–308.
   PubMed Web of Science ®Google Scholar
• Obaseiki-Ebor EE, Afonya TC. In vitro evaluation of the anticandiasis activity of honey distillate (HY-1) compared with that of some antimycotic agents. J Pharm Pharmacol 1984; 36: 283–284.
   PubMed Web of Science ®Google Scholar
• Gil M, Ferreres F, Ortiz A, Subra E, Tomas-Barberan FA. Plant phenolic metabolites and floral origin of rosemary honey. J Agric Food Chem 1995; 43: 2833–2838.
   Web of Science ®Google Scholar
• Kucuk M, Kolayli S, Karaoglu S, . Biological activities and chemical composition of three honeys of different types from Anatolia. Food Chem 2007; 100: 526–534.
   Web of Science ®Google Scholar
• Cushnie TPT, Lamb AJ. Antimicrobial activity of flavonoids. Int J Antimicrob Ag 2005; 26: 343–356.
   PubMed Web of Science ®Google Scholar
• Andrade P, Ferreres F, Gil MI, Tomas-Barberan FA. Determination of phenolic compounds in honeys with different floral origin by capillary zone electrophoresis. Food Chem 1997; 60: 79–84.
   Web of Science ®Google Scholar
• Allen KL. The potential for using honey to treat wounds infected with MRSA and VRE, First World Healing Congress, 12–13 September, Melbourne, Australia, 2000.
   Google Scholar